SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about clarification

12 Jul 2021 Evaluate

Granules India has informed that, there were certain messages floating in social media on Friday, 9th July 2021 that the Company is being sold to some PE investors. The company deny these messages as they are utterly false and malicious. The management continues to remain committed to the growth of the Company. This is for the information and dissemination to the members of the exchange.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

689.10 2.35 (0.34%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×